Advanced search×

Timing of renal replacement therapy and clinical outcomes in critically ill patients with severe acute kidney injury

J Crit Care 24(1):12 (2009) PMID 19272549

Purpose: The aim of this study is to evaluate the relationship between timing of renal replacement therapy (RRT) in severe acute kidney injury and clinical outcomes. Methods: This was a prospective multicenter observational study conducted at 54 intensive care units (ICUs) in 23 countries enrolling 1238 patients. Results: Timing of RRT was stratified into ''early'' and ''late'' by median urea and creatinine at the time RRT was started. Timing was also categorized temporally from ICU admission into early (5 days). Renal replacement therapy timing by serum urea showed no significant difference in crude (63.4% for urea @?24.2 mmol/L vs 61.4% for urea >24.2 mmol/L; odds ratio [OR], 0.92; 95% confidence interval [CI], 0.73-1.15; P = .48) or covariate-adjusted mortality (OR, 1.25; 95% CI, 0.91-1.70; P = .16). When stratified by creatinine, late RRT was associated with lower crude (53.4% for creatinine >309 @mmol/L vs 71.4% for creatinine @?309 @mmol/L; OR, 0.46; 95% CI, 0.36-0.58; P < .0001) and covariate-adjusted mortality (OR, 0.51; 95% CI, 0.37-0.69; P < .001). However, for timing relative to ICU admission, late RRT was associated with greater crude (72.8% vs 62.3% vs 59%, P < .001) and covariate-adjusted mortality (OR, 1.95; 95% CI, 1.30-2.92; P = .001). Overall, late RRT was associated with a longer duration of RRT and stay in hospital and greater dialysis dependence. Conclusion: Timing of RRT, a potentially modifiable factor, might exert an important influence on patient survival. However, this largely depended on its definition. Late RRT (days from admission) was associated with a longer duration of RRT, longer hospital stay, and higher dialysis dependence.

Copyright © 2009 Elsevier Ltd. All rights reserved.

DOI: 10.1016/j.jcrc.2007.12.017
Version: za2963e q8za6 q8zb7 q8zc6 q8zd0 q8zed q8zf6 q8zg7

Similar articles you may find interesting…

  1. Outcomes of salvage autologous versus allogeneic hematopoietic cell transplantation for relapsed multiple myeloma after initial autologous h...

    J Clin Med Res 5(3):174-84 (2013) PMID 23671543

    Standard therapy for multiple myeloma (MM) includes initial autologous hematopoietic cell transplantation (autoHCT1) but this is not curative and most patients will relapse. Role of salvage autoHCT2 or allogeneic HCT (alloHCT2) is undefined. MM patients who relapsed a...
  2. Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy (3C) Study: background, rationale, and study protocol.

    Transplantation Research 2(1):7 (2013) PMID 23641902

    BACKGROUND: Kidney transplantation is the best treatment for patients with end-stage renal failure, but uncertainty remains about the best immunosuppression strategy. Long-term graft survival has not improved substantially, and one possible explanation is calcineurin inhibitor (CNI)...
  3. Development of Contrast-Induced Nephropathy in Subarachnoid Hemorrhage: a Single Center Perspective.

    Neurocrit Care (2013) PMID 23653268

    The incidence of CIN in SAH patients is comparable to previously published reports on non-neurological cohorts. No definite association was noted with any predisposing factors postulated to be responsible for CIN, except for advanced age. Concurrent use of 3 % HTS was not associated with CIN in thi...